Related Experiment Video
Updated: Sep 22, 2025

Isolation of Pulmonary Artery Smooth Muscle Cells from Neonatal Mice
Published on: October 19, 2013
miR-155-5p regulates hypoxia-induced pulmonary artery smooth muscle cell function by targeting PYGL
Guowen Wang1, Xuefang Tao1, Linlin Peng2
1Department of Respiratory Medicine, Affiliated Hospital of Shaoxing University, Shaoxing, Zhejiang, China.
Abstract:
Pulmonary arterial hypertension (PAH) is a cardiovascular disease that has high incidence and causes massive deaths. miR-155-5p/PYGL pathway was revealed to play a crucial role in PAH by weighted gene co-expression network analysis (WGCNA). The potential mechanism of miR-155-5p in regulating hypoxia-induced pulmonary artery smooth muscle cell (PASMC) function was analyzed through in vitro experiments. Hypoxia treatment stimulated the proliferation of PASMCs and increased the expression of vascular endothelial growth factor (VEGF) and hypoxia-inducible factor-1α (HIF-1α). At the same time, revealed by qRT-PCR and western blot, the level of miR-155-5p was raised, and the level of PYGL was decreased in hypoxia-induced PASMCs. Through CCK-8 assay, transwell assay and flow cytometry, it was revealed that miR-155-5p inhibitor remarkably inhibited the cell proliferation and migration and decreased the proportion of hypoxia-stimulated PASMCs in S and G2/M phases. Dual-luciferase reporter system was subsequently applied to validate the straight regulation of miR-155-5p on PYGL based on the analysis of online database. Furthermore, siPYGL was revealed to reverse the influence of miR-155-5p inhibitor on hypoxia-induced PASMCs. These outcomes indicate that the increased level of miR-155-5p in hypoxia-stimulated PASMCs could enhance the cell proliferation, cell migration, and cell cycle progression by targeting PYGL directly. This study may supply novel treatment strategies for PAH.Abbreviations: PH, pulmonary hypertension; PAH, pulmonary arterial hypertension; WGCNA, weighted gene co-expression network analysis; PASMCs, pulmonary artery smooth muscle cells; VEGF, vascular endothelial growth factor; HIF-1α, hypoxia-inducible factor-1α; SMCs, smooth muscle cells; DEGs, differentially expressed genes; GEO, Gene Expression Omnibus; GO, Gene Ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; FBS, fetal bovine serum; OD, optical density; BCA, bicinchoninic acid; PVDF, polyvinylidene fluoride; PBS, phosphate-buffered saline; BP, biological process; MF, molecular function; CC, cell component.
Insights
Pulmonary arterial hypertension (PAH) involves increased miR-155-5p targeting PYGL in pulmonary artery smooth muscle cells (PASMCs). This pathway drives cell proliferation and migration, suggesting new therapeutic targets for PAH.
Area of Science:
- Cardiovascular Biology
- Molecular Medicine
- Cellular Physiology
Background:
- Pulmonary arterial hypertension (PAH) is a severe cardiovascular disease with high mortality.
- The miR-155-5p/PYGL pathway has been implicated in PAH pathogenesis.
- Understanding cellular mechanisms in PAH is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role of miR-155-5p in regulating hypoxia-induced pulmonary artery smooth muscle cell (PASMC) function.
- To elucidate the molecular mechanism by which miR-155-5p affects PASMCs in the context of PAH.
- To identify potential therapeutic targets within the miR-155-5p/PYGL pathway for PAH treatment.
Main Methods:
- Weighted gene co-expression network analysis (WGCNA) to identify key pathways.
- In vitro experiments using hypoxia-treated PASMCs.
- Quantitative real-time PCR (qRT-PCR) and Western blot to measure gene and protein expression.
- Cell proliferation (CCK-8), migration (Transwell), and cell cycle assays (Flow cytometry).
- Dual-luciferase reporter assay to confirm direct interaction between miR-155-5p and PYGL.
Main Results:
- Hypoxia increased PASMC proliferation, VEGF, HIF-1α, and miR-155-5p levels, while decreasing PYGL expression.
- miR-155-5p inhibition suppressed hypoxia-induced PASMC proliferation, migration, and altered cell cycle progression.
- Direct regulation of PYGL by miR-155-5p was confirmed.
- Silencing PYGL reversed the effects of miR-155-5p inhibition on PASMCs.
Conclusions:
- Increased miR-155-5p in hypoxia-stimulated PASMCs promotes proliferation, migration, and cell cycle progression by directly targeting PYGL.
- The miR-155-5p/PYGL axis represents a significant mechanism in PAH pathogenesis.
- This pathway offers potential novel therapeutic strategies for treating pulmonary arterial hypertension.
More Related Videos
13:32Videomorphometric Analysis of Hypoxic Pulmonary Vasoconstriction of Intra-pulmonary Arteries Using Murine Precision Cut Lung Slices
Published on: January 14, 2014
09:17Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
Published on: August 2, 2018
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...